Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

11.2K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
11.2K
In Vitro Drug Release Testing: Overview, Development and Validation01:10

In Vitro Drug Release Testing: Overview, Development and Validation

318
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
318
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

4.1K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
4.1K
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

215
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
215
Sustainable Development01:43

Sustainable Development

14.8K
As the human population continues to grow and use resources, we must be mindful of our planet’s natural limits. Sustainable development provides a pathway to maintain and improve human life now while also ensuring that future generations will have the resources that they need. The long-term success of sustainability efforts rests on understanding the interplay between human actions and ecological systems.
14.8K
Genetic Screens02:46

Genetic Screens

5.6K
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
5.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intracellular Delivery of Peptides and Proteins with an Engineered Membrane Translocation Domain.

ACS chemical biology·2026
Same author

Discovery of a Minimally Charged Cell-Penetrating Peptide.

Biochemistry·2026
Same author

Intracellular Delivery of Peptides and Proteins with an Engineered Membrane Translocation Domain.

bioRxiv : the preprint server for biology·2026
Same author

Systemic Delivery of Functional Proteins Into Plants Using an Engineered Membrane Translocation Domain.

Plant biotechnology journal·2026
Same author

Extracellular Vesicle Lipid Cargo Orchestrates Lung Inflammation and Resolution.

American journal of respiratory cell and molecular biology·2026
Same author

Endosomal Escape of Lipid Nanoparticles: A Perspective on the Literature Data.

ACS nano·2025

Related Experiment Video

Updated: Jan 21, 2026

Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments
07:50

Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments

Published on: October 25, 2024

2.3K

Developments with bead-based screening for novel drug discovery.

Dehua Pei1, George Appiah Kubi1

  • 1Department of Chemistry and Biochemistry, The Ohio State University , Columbus , OH , USA.

Expert Opinion on Drug Discovery
|July 24, 2019
PubMed
Summary
This summary is machine-generated.

One-bead-one-compound (OBOC) libraries offer rapid drug discovery but faced challenges. Now, overcome technical hurdles enable screening of diverse molecules against difficult targets, advancing drug development.

Keywords:
Bead-based screeningcombinatorial librarydrug discoveryhigh-throughput screeningone-bead-one-compound library

More Related Videos

Author Spotlight: Cost-Effective Transcriptomic Drug Screening - Unlocking New Targets
06:40

Author Spotlight: Cost-Effective Transcriptomic Drug Screening - Unlocking New Targets

Published on: February 23, 2024

1.8K
Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

5.5K

Related Experiment Videos

Last Updated: Jan 21, 2026

Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments
07:50

Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments

Published on: October 25, 2024

2.3K
Author Spotlight: Cost-Effective Transcriptomic Drug Screening - Unlocking New Targets
06:40

Author Spotlight: Cost-Effective Transcriptomic Drug Screening - Unlocking New Targets

Published on: February 23, 2024

1.8K
Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

5.5K

Area of Science:

  • Medicinal Chemistry
  • Drug Discovery
  • Combinatorial Chemistry

Background:

  • Combinatorial chemistry, particularly the one-bead-one-compound (OBOC) library method, is a cost-effective approach for identifying drug hits and leads.
  • First-generation OBOC libraries faced challenges including structural identification of non-peptidic compounds, screening biases, high false positive rates, and scalability issues.

Purpose of the Study:

  • To review the technical challenges encountered in the application of OBOC libraries for drug discovery.
  • To discuss strategies developed to overcome these challenges over the past two decades.
  • To highlight the current capabilities and future directions of OBOC library technology.

Main Methods:

  • Review of literature on OBOC library development and application.
  • Analysis of strategies to address limitations in structural identification, screening, and scalability.
  • Discussion of advancements in synthesizing and screening metabolically stable and conformationally rigidified molecules.

Main Results:

  • Most technical challenges associated with first-generation OBOC libraries have been addressed.
  • OBOC libraries of metabolically stable and conformationally rigidified molecules (e.g., macrocyclic peptides, D-peptides) can now be routinely synthesized and screened.
  • These advancements facilitate the discovery of hits against previously undruggable targets, such as intracellular protein-protein interactions.

Conclusions:

  • Overcome technical challenges and new intracellular delivery technologies enable routine use of OBOC libraries for drug discovery.
  • OBOC libraries are effective for identifying initial hits against challenging targets like intracellular protein-protein interactions.
  • Further research is needed to broaden the utility of OBOC methods for non-peptidic chemical scaffolds.